Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 07 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | BANDHAN Nifty 50 Index Fund |
|---|---|
| 07 Jan 2013 | ₹100.00 |
| 25 Feb 2014 | ₹104.51 |
| 16 Apr 2015 | ₹148.06 |
| 03 Jun 2016 | ₹141.35 |
| 23 Jul 2017 | ₹172.46 |
| 10 Sep 2018 | ₹201.25 |
| 30 Oct 2019 | ₹210.96 |
| 17 Dec 2020 | ₹223.55 |
| 04 Feb 2022 | ₹287.09 |
| 26 Mar 2023 | ₹281.48 |
| 13 May 2024 | ₹371.41 |
| 02 Jul 2025 | ₹432.90 |
| 20 Aug 2026 | ₹417.30 |
| Metric | Bandhan · Direct · IDCW NAV ₹49.34 Very High risk ★★★★☆ | Category median Index Funds · 271 funds |
|---|---|---|
| -2.37% | +5.06% | |
| +8.89% | +7.78% | |
| +9.15% | +8.94% | |
| +10.78% | +10.39% | |
| +11.06% | +7.54% | |
| +7.50% | — | |
| +12.00% | +8.12% | |
| +12.04% | +12.83% | |
| +11.93% | +11.97% | |
| Risk | ||
| 13.12% | 13.54% | |
| 0.18 | 0.16 | |
| 0.25 | 0.22 | |
| -43.74% | -15.77% | |
| Nifty 50 | — | |
| +0.96% | +0.53% | |
| 1.00 | 1.00 | |
| 102.3% | 102.2% | |
| 96.6% | 98.0% | |
| 0.14% | 0.34% | |
| ₹2,633Cr | ₹191.88Cr | |
| — | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 3% | 38% | |
| Abhishek Jain | — | |
| 07 Jan 2013 | — | |
| 50 | — | |
| 53.4% | — | |
| 0.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.